Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
David C Rupp, David Canty, Catherine Rhéaume, Birgitte Sondergaard, Celina Niño, Ron S Broide & Amy D Brideau-Andersen. (2023) A Preclinical Study Comparing the Activity and Potency of OnabotulinumtoxinA and PrabotulinumtoxinA. Clinical, Cosmetic and Investigational Dermatology 16, pages 581-591.
Read now
Read now
Jürgen Frevert, Ki Young Ahn, Mee Young Park & Owen Sunga. (2018) Comparison of botulinum neurotoxin type A formulations in Asia. Clinical, Cosmetic and Investigational Dermatology 11, pages 327-331.
Read now
Read now
Michael Kennelly, Lonny Green, Nancy Alvandi, Salim Wehbe, John Joseph Smith$suffix/text()$suffix/text(), Scott MacDiarmid, Jeffrey Mangel, Marc Schwartz, Tamer Aboushwareb & Brian Murray. (2018) Clean intermittent catheterization rates after initial and subsequent treatments with onabotulinumtoxinA for non-neurogenic overactive bladder in real-world clinical settings. Current Medical Research and Opinion 34:10, pages 1771-1776.
Read now
Read now
Christine Hosp & Henning Hamm. (2017) Safety of available and emerging drug therapies for hyperhidrosis. Expert Opinion on Drug Safety 16:9, pages 1039-1049.
Read now
Read now
Articles from other publishers (29)
Ileana M. Howard & Atul T. Patel. (2023) Spasticity evaluation and management tools. Muscle & Nerve 67:4, pages 272-283.
Crossref
Crossref
Parisa Gazerani. (2022) How Does Botulinum Toxin Inhibit Itch?. Toxins 14:10, pages 701.
Crossref
Crossref
Paula A. Benítez. (2021) Onabotulinumtoxin A for correcting trapezius muscle hypertrophy in Asian women. Journal of Cosmetic Dermatology 21:6, pages 2677-2679.
Crossref
Crossref
Wu‐chao Liu, Jun‐hui Su, Ya Feng, Xue‐rui Xiang, Li‐zhen Pan, Ying Liu, Lin Ma, Zhi‐yu Nie, Xue‐ping Zhang & Ling‐jing Jin. (2022) Dynamic muscle paralytic effects of a novel botulinum toxin A free of neurotoxin‐associated proteins. Pharmacology Research & Perspectives 10:3.
Crossref
Crossref
Pengxu Wei. (2022) Botulinum Toxin Injection for the Treatment of Upper Esophageal Sphincter Dysfunction. Toxins 14:5, pages 321.
Crossref
Crossref
Alexander D. Nassif, Ricardo F. Boggio, Sheila Espicalsky & Gladstone E. L. Faria. (2022) High Precision Use of Botulinum Toxin Type A (BONT-A) in Aesthetics Based on Muscle Atrophy, Is Muscular Architecture Reprogramming a Possibility? A Systematic Review of Literature on Muscle Atrophy after BoNT-A Injections. Toxins 14:2, pages 81.
Crossref
Crossref
Thays Crosara Abrahão Cunha, Ana Claudia Gontijo Couto, Eduardo Januzzi, Rafael Tardin Rosa Ferraz Gonçalves, Graziella Silva & Cassia Regina Silva. (2021) Analgesic potential of different available commercial brands of botulinum neurotoxin-A in formalin-induced orofacial pain in mice. Toxicon: X 12, pages 100083.
Crossref
Crossref
Kateřina Menšíková, Martin Nevrlý, Lenka Hvizdošová, Michaela Kaiserová, Sandra Kurčová, Miroslav Vaštík, Jan Bardoň, Tereza Bartoníková, Zuzana Grambalová, Aleš Grambal, Pavel Otruba & Petr Kaňovský. (2021) The current state of pharmacotherapy for extrapyramidal diseases. Neurologie pro praxi 22:3, pages 183-193.
Crossref
Crossref
Joely Kaufman-Janette, Sue Ellen Cox, Steven Dayan & John Joseph. (2021) Botulinum Toxin Type A for Glabellar Frown Lines: What Impact of Higher Doses on Outcomes?. Toxins 13:7, pages 494.
Crossref
Crossref
Ruth Kent, Adrian Robertson, Sandra Quiñones Aguilar, Charalampos Tzoulis & John Maltman. (2021) Real-World Dosing of OnabotulinumtoxinA and IncobotulinumtoxinA for Cervical Dystonia and Blepharospasm: Results from TRUDOSE and TRUDOSE II. Toxins 13:7, pages 488.
Crossref
Crossref
Supriyo Choudhury, Mark R. Baker, Suparna Chatterjee & Hrishikesh Kumar. (2021) Botulinum Toxin: An Update on Pharmacology and Newer Products in Development. Toxins 13:1, pages 58.
Crossref
Crossref
V.Yu. Avtomonov & E.A. Razumovskaya. (2021) Botulinum toxins in cosmetology: clarifications. Klinicheskaya dermatologiya i venerologiya 20:4, pages 135.
Crossref
Crossref
P. Chaichanavichkij, P. F. Vollebregt, S. M. Scott & C. H. Knowles. (2020) Botulinum toxin type A for the treatment of dyssynergic defaecation in adults: a systematic review. Colorectal Disease 22:12, pages 1832-1841.
Crossref
Crossref
Mark S. Nestor, David Arnold & Daniel Fischer. (2020) The mechanisms of action and use of botulinum neurotoxin type A in aesthetics: Key Clinical Postulates II. Journal of Cosmetic Dermatology 19:11, pages 2785-2804.
Crossref
Crossref
Alberto Esquenazi, Mauricio R. Delgado, Robert A. Hauser, Philippe Picaut, Keith Foster, Andreas Lysandropoulos & Jean-Michel Gracies. (2020) Duration of Symptom Relief Between Injections for AbobotulinumtoxinA (Dysport®) in Spastic Paresis and Cervical Dystonia: Comparison of Evidence From Clinical Studies. Frontiers in Neurology 11.
Crossref
Crossref
David Rupp, Greg Nicholson, David Canty, Joanne Wang, Catherine Rhéaume, Linh Le, Lance E. Steward, Mark Washburn, Birgitte P. Jacky, Ron S. Broide, Wolfgang G. Philipp-Dormston, Mitchell F. Brin & Amy Brideau-Andersen. (2020) OnabotulinumtoxinA Displays Greater Biological Activity Compared to IncobotulinumtoxinA, Demonstrating Non-Interchangeability in Both In Vitro and In Vivo Assays. Toxins 12:6, pages 393.
Crossref
Crossref
Lenka Hvizdošová, Pavel Otruba, Martin Nevrlý & Petr Kaňovský. (2020) Botulinum toxin A in the treatment of dystonia. Neurologie pro praxi 21:1, pages 21-26.
Crossref
Crossref
Masahiro Abo, Takashi Shigematsu, Hiroyoshi Hara, Yasuko Matsuda, Akinori Nimura, Yoshiyuki Yamashita & Kaoru Takahashi. (2020) Efficacy and Safety of OnabotulinumtoxinA 400 Units in Patients with Post-Stroke Upper Limb Spasticity: Final Report of a Randomized, Double-Blind, Placebo-Controlled Trial with an Open-Label Extension Phase. Toxins 12:2, pages 127.
Crossref
Crossref
C. Koh, C.V. Melling, C. Jennings, M. Lewis & A. Goyal. (2019) Efficacy of electromotive drug administration in delivering botulinum toxin a in children with neuropathic detrusor overactivity—outcomes of a pilot study. Journal of Pediatric Urology 15:5, pages 552.e1-552.e8.
Crossref
Crossref
Hee Young Son. (2019) Practical Issue of Botulinum Toxin use Liquid Type, Storage and Reuse. Journal of The Korean Society of Laryngology, Phoniatrics and Logopedics 30:1, pages 9-11.
Crossref
Crossref
Julián Balanta-Melo, Viviana Toro-Ibacache, Kornelius Kupczik & Sonja Buvinic. (2019) Mandibular Bone Loss after Masticatory Muscles Intervention with Botulinum Toxin: An Approach from Basic Research to Clinical Findings. Toxins 11:2, pages 84.
Crossref
Crossref
Elena Fonfria. 2018. Neurotoxins. Neurotoxins.
Elena Fonfria, Jacquie Maignel, Stephane Lezmi, Vincent Martin, Andrew Splevins, Saif Shubber, Mikhail Kalinichev, Keith Foster, Philippe Picaut & Johannes Krupp. (2018) The Expanding Therapeutic Utility of Botulinum Neurotoxins. Toxins 10:5, pages 208.
Crossref
Crossref
JTE Lim, DK Loh, K Soh & O Sunga. (2017) Efficacy and patient satisfaction with incobotulinumtoxinA for the treatment of glabellar frown lines. Singapore Medical Journal 58:10, pages 606-609.
Crossref
Crossref
Emmanuel Chartier‐Kastler, Eric Rovner, Zsolt Hepp, Kristin Khalaf, Quanhong Ni & Michael Chancellor. (2015) Patient‐reported goal achievement following onabotulinumtoxinA treatment in patients with neurogenic detrusor overactivity. Neurourology and Urodynamics 35:5, pages 595-600.
Crossref
Crossref
Anna Rita Bentivoglio, Alessandra Del Grande, Martina Petracca, Tamara Ialongo & Lucia Ricciardi. (2015) Clinical differences between botulinum neurotoxin type A and B. Toxicon 107, pages 77-84.
Crossref
Crossref
Stéphanie Simon, Uwe Fiebig, Yvonne Liu, Rob Tierney, Julie Dano, Sylvia Worbs, Tanja Endermann, Marie-Claire Nevers, Hervé Volland, Dorothea Sesardic & Martin Dorner. (2015) Recommended Immunological Strategies to Screen for Botulinum Neurotoxin-Containing Samples. Toxins 7:12, pages 5011-5034.
Crossref
Crossref
Yu-Ching Lin. (2015) Predicting the Response to Botulinum Toxin Treatment in Children With Cerebral Palsy. Archives of Physical Medicine and Rehabilitation 96:4, pages 760.
Crossref
Crossref
Wolfgang H. Jost. (2015) ‘Similar To’ Is Not ‘Identical With’, and ‘Identical With’ Is Not ‘The Same As’. Drugs in R&D 15:1, pages 11-12.
Crossref
Crossref